Display options
Share it on

Ther Adv Psychopharmacol. 2015 Aug;5(4):237-42. doi: 10.1177/2045125315584871.

Effectiveness of ultra-rapid dose titration of clozapine for treatment-resistant bipolar mania: case series.

Therapeutic advances in psychopharmacology

Cana Aksoy Poyraz, Şenol Turan, Ömer Faruk Demirel, Nazife Gamze Usta Sağlam, Nazım Yıldız, Alaattin Duran

Affiliations

  1. Department of Psychiatry, Cerrahpa?a Medical School, Halaskargazi cad. No: 81 Çiçek apt. daire: 8, Osmanbey Istanbul, Turkey.
  2. Department of Psychiatry, Cerrahpa?a Medical School, University of Istanbul, Turkey.

PMID: 26301080 PMCID: PMC4535045 DOI: 10.1177/2045125315584871

Abstract

Treatment of severe and refractory manic episodes in hospital settings can occasionally be very difficult. In particular, severely excited patients showing aggressive, hostile, impulsive behaviours frequently require physical restraint and seclusion, high doses of antipsychotics and benzodiazepines, and sometimes, electroconvulsive therapy. Hospital stay is generally prolonged and such patients cause great emotional distress for other patients in the ward and clinical staff involved in their care. Here we report on three patients with a diagnosis of bipolar disorder and one patient with a diagnosis of schizoaffective disorder bipolar subtype, all of whom were hospitalized for severe manic episodes with psychotic features. These patients were extremely difficult to manage in the ward as no response could be obtained in the first week of treatment despite high doses of antipsychotics and benzodiazepine administration. The introduction and rapid titration of clozapine proved remarkably effective and was well tolerated in the acute management of these patients. We observed that clozapine had a superior and fast mood stabilization effect with rapid titration and could be extremely helpful in the management of such patients.

Keywords: bipolar disorder; clozapine; mania; rapid titration

References

  1. Schizophr Bull. 1991;17(2):247-61 - PubMed
  2. Aust N Z J Psychiatry. 2012 Sep;46(9):816-25 - PubMed
  3. J Neuropsychiatry Clin Neurosci. 1992 Fall;4(4):454-7 - PubMed
  4. Am J Psychiatry. 1999 Jul;156(7):990-9 - PubMed
  5. Am J Psychiatry. 1991 Sep;148(9):1265-6 - PubMed
  6. Neurology. 1991 Mar;41(3):369-71 - PubMed
  7. Aust N Z J Psychiatry. 2013 Jan;47(1):93 - PubMed
  8. J Affect Disord. 2014 Sep;166:168-72 - PubMed
  9. Med Sci Monit. 2004 Feb;10 (2):PI19-23 - PubMed
  10. Int J Neuropsychopharmacol. 2012 Oct;15(9):1351-71 - PubMed
  11. Drug Saf. 2007;30(1):47-57 - PubMed
  12. J Clin Psychopharmacol. 2005 Feb;25(1):32-41 - PubMed
  13. Acta Psychiatr Scand. 2014 Jul;130(1):69-70 - PubMed
  14. Bipolar Disord. 2012 Dec;14(8):863-9 - PubMed
  15. Bipolar Disord. 2015 May;17(3):235-47 - PubMed
  16. J Clin Psychiatry. 1994 Jul;55(7):295-300 - PubMed
  17. J Clin Psychiatry. 1992 Nov;53(11):395-7 - PubMed
  18. Expert Opin Drug Saf. 2003 May;2(3):233-47 - PubMed
  19. Neurology. 1994 Dec;44(12):2247-9 - PubMed
  20. Int J Clin Pract. 2008 Aug;62(8):1237-45 - PubMed
  21. J Clin Psychiatry. 1991 Oct;52(10):411-4 - PubMed
  22. Schizophr Res. 2012 Nov;141(2-3):173-8 - PubMed
  23. Schizophr Res. 2002 Jan 1;53(1-2):1-6 - PubMed
  24. Biol Psychiatry. 1996 Mar 1;39(5):367-70 - PubMed
  25. Acta Psychiatr Scand. 2014 Jul;130(1):25-9 - PubMed
  26. Ther Adv Psychopharmacol. 2011 Apr;1(2):47-66 - PubMed
  27. Acta Psychiatr Scand. 1988 May;77(5):524-9 - PubMed

Publication Types